Central nervous system disorders after use of dolutegravir: evidence from preclinical and clinical studies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Central nervous system disorders after use of dolutegravir: evidence from preclinical and clinical studies ; volume:75 ; number:5 ; day:21 ; month:8 ; year:2023 ; pages:1138-1151 ; date:10.2023
Pharmacological reports ; 75, Heft 5 (21.8.2023), 1138-1151, 10.2023
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Jakimiuk, Alicja
Piechal, Agnieszka
Wiercińska-Drapało, Alicja
Nowaczyk, Alicja
Mirowska-Guzel, Dagmara
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s43440-023-00515-y
- URN
-
urn:nbn:de:101:1-2023122316102157803784
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jakimiuk, Alicja
- Piechal, Agnieszka
- Wiercińska-Drapało, Alicja
- Nowaczyk, Alicja
- Mirowska-Guzel, Dagmara
- SpringerLink (Online service)
Ähnliche Objekte (12)
Clinical Observations on functional nervous Disorders
Therapie der Nervenkrankheiten : = Treatment of nervous disorders
Dolutegravir: Nutzenbewertung gemäß § 35a SGB V
CatWalk XT gait parameters: a review of reported parameters in pre-clinical studies of multiple central nervous system and peripheral nervous system disease models
Knowledge and perceptions about Dolutegravir and Dolutegravir counselling: a qualitative study among women living with HIV
Anxiety disorders in acute central nervous system infections
Preclinical studies of low back pain
Creation of a long-acting nanoformulated dolutegravir
Tryptophan metabolism and its relationship with central nervous system toxicity in people living with HIV switching from efavirenz to dolutegravir
Extracellular vesicle therapy for traumatic central nervous system disorders
Probing disorders of the nervous system using reprogramming approaches
Should dolutegravir always be withheld in people with HIV on dolutegravir with incident diabetes mellitus? a case report
Clinical Observations on functional nervous Disorders
Therapie der Nervenkrankheiten : = Treatment of nervous disorders
Dolutegravir: Nutzenbewertung gemäß § 35a SGB V
CatWalk XT gait parameters: a review of reported parameters in pre-clinical studies of multiple central nervous system and peripheral nervous system disease models
Knowledge and perceptions about Dolutegravir and Dolutegravir counselling: a qualitative study among women living with HIV
Anxiety disorders in acute central nervous system infections
Preclinical studies of low back pain
Creation of a long-acting nanoformulated dolutegravir
Tryptophan metabolism and its relationship with central nervous system toxicity in people living with HIV switching from efavirenz to dolutegravir
Extracellular vesicle therapy for traumatic central nervous system disorders
Probing disorders of the nervous system using reprogramming approaches
Should dolutegravir always be withheld in people with HIV on dolutegravir with incident diabetes mellitus? a case report
Clinical Observations on functional nervous Disorders
Therapie der Nervenkrankheiten : = Treatment of nervous disorders
Dolutegravir: Nutzenbewertung gemäß § 35a SGB V
CatWalk XT gait parameters: a review of reported parameters in pre-clinical studies of multiple central nervous system and peripheral nervous system disease models
Knowledge and perceptions about Dolutegravir and Dolutegravir counselling: a qualitative study among women living with HIV
Anxiety disorders in acute central nervous system infections
Preclinical studies of low back pain
Creation of a long-acting nanoformulated dolutegravir
Tryptophan metabolism and its relationship with central nervous system toxicity in people living with HIV switching from efavirenz to dolutegravir
Extracellular vesicle therapy for traumatic central nervous system disorders
Probing disorders of the nervous system using reprogramming approaches